About William Hodder
Form D filings for NFlection Therapeutics from 2022 to 2023 list William Hodder as president and director.
William Hodder first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name William Hodder in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people William Hodder works with at each company, as listed on that company's latest Form D.
NFlection Therapeutics, Inc. · Form D, Jul 21, 2023